Antiproliferative and apoptotic effect of Morus nigra extract on human prostate cancer cells
Özet
Background: Morus nigra L. belongs to the family Moraceae and is frequently used in traditional medicine. Numerous studies have investigated the antiproliferative effects of various extracts of different Morus species, but studies involving the in vitro cytotoxic effect of M. nigra extract are very limited. The purpose of this study was to evaluate the phenolic composition and antioxidant activity of dimethyl sulfoxide extract of M. nigra (DEM) and to investigate, for the first time, the probable cytotoxic effect in human prostate adenocarcinoma (PC-3) cells together with the mechanism involved. Methods: Total polyphenolic contents (TPC), ferric reducing antioxidant power (FRAP) and phenolic compounds of DEM were evaluated using spectrophotometric procedures and HPLC. The cytotoxic effect of DEM on PC-3 cells was revealed using the MTT assay. Mechanisms involved in the cytotoxic effect of DEM on PC-3 cells were then investigated in terms of apoptosis, mitochondrial membrane potential and cell cycle using flow cytometry, while caspase activity was investigated using luminometric analysis. Results: TPC and FRAP values were 20.7 ± 0.3 mg gallic acid equivalents and 48.8 ± 1.6 mg trolox equivalents per g sample, respectively. Ascorbic acid and chlorogenic acid were the major phenolic compounds detected at HPLC analysis. DEM arrested the cell cycle of PC-3 cells at the G1 phase, induced apoptosis via increased caspase activity and reduced mitochondrial membrane potential. Conclusions: Our results indicate that M. nigra may be a novel candidate for the development of new natural product based therapeutic agents against prostate cancer.
Anahtar Kelimeler
Tam Kayıt
| Alan | Değer | Dil |
|---|---|---|
| dc.contributor.author | Turan, Ibrahim | |
| dc.contributor.author | Demir, Selim | |
| dc.contributor.author | Kilinc, Kagan | |
| dc.contributor.author | Burnaz, Nesibe Arslan | |
| dc.contributor.author | Yaman, Serap Ozer | |
| dc.contributor.author | Akbulut, Kubra | |
| dc.contributor.author | Mentese, Ahmet | |
| dc.contributor.author | Aliyazicioglu, Yuksel | |
| dc.contributor.author | Deger, Orhan | |
| dc.date.accessioned | 2026-10-22T10:23:39.430221169Z | |
| dc.date.available | 2026-10-22T10:23:39.430221169Z | |
| dc.date.issued | 2017 | |
| dc.description.abstract | Background: Morus nigra L. belongs to the family Moraceae and is frequently used in traditional medicine. Numerous studies have investigated the antiproliferative effects of various extracts of different Morus species, but studies involving the in vitro cytotoxic effect of M. nigra extract are very limited. The purpose of this study was to evaluate the phenolic composition and antioxidant activity of dimethyl sulfoxide extract of M. nigra (DEM) and to investigate, for the first time, the probable cytotoxic effect in human prostate adenocarcinoma (PC-3) cells together with the mechanism involved. Methods: Total polyphenolic contents (TPC), ferric reducing antioxidant power (FRAP) and phenolic compounds of DEM were evaluated using spectrophotometric procedures and HPLC. The cytotoxic effect of DEM on PC-3 cells was revealed using the MTT assay. Mechanisms involved in the cytotoxic effect of DEM on PC-3 cells were then investigated in terms of apoptosis, mitochondrial membrane potential and cell cycle using flow cytometry, while caspase activity was investigated using luminometric analysis. Results: TPC and FRAP values were 20.7 ± 0.3 mg gallic acid equivalents and 48.8 ± 1.6 mg trolox equivalents per g sample, respectively. Ascorbic acid and chlorogenic acid were the major phenolic compounds detected at HPLC analysis. DEM arrested the cell cycle of PC-3 cells at the G1 phase, induced apoptosis via increased caspase activity and reduced mitochondrial membrane potential. Conclusions: Our results indicate that M. nigra may be a novel candidate for the development of new natural product based therapeutic agents against prostate cancer. | |
| dc.identifier.doi | 10.1016/j.jsps.2016.06.002 | |
| dc.identifier.eissn | 2213-7475 | |
| dc.identifier.endpage | 248 | |
| dc.identifier.issn | 1319-0164 | |
| dc.identifier.issue | 2 | |
| dc.identifier.pmid | 28344475 | |
| dc.identifier.scopus | 2-s2.0-84978401518 | |
| dc.identifier.startpage | 241 | |
| dc.identifier.uri | https://rdlopen.rawdatalibrary.net/r/gumushane/15152 | |
| dc.identifier.volume | 25 | |
| dc.identifier.wos | WOS:000396406300011 | |
| dc.language.iso | en | |
| dc.publisher | Elsevier B.V. | |
| dc.relation.ispartof | Saudi Pharmaceutical Journal | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | Apoptosis | |
| dc.subject | Cell cycle | |
| dc.subject | Cytotoxicity | |
| dc.subject | Moraceae | |
| dc.subject | Morus nigra L. | |
| dc.subject | Prostate neoplasms | |
| dc.subject.classification | Pharmacology & Pharmacy | |
| dc.subject.other | 3,4 dihydroxy benzoic acid | |
| dc.subject.other | antineoplastic agent | |
| dc.subject.other | antioxidant | |
| dc.subject.other | ascorbic acid | |
| dc.subject.other | caffeic acid | |
| dc.subject.other | caspase 3 | |
| dc.subject.other | caspase 7 | |
| dc.subject.other | chlorogenic acid | |
| dc.subject.other | cisplatin | |
| dc.subject.other | dimethyl sulfoxide | |
| dc.subject.other | effector caspase | |
| dc.subject.other | epigallocatechin gallate | |
| dc.subject.other | gallic acid | |
| dc.subject.other | morus nigra extract | |
| dc.subject.other | para coumaric acid | |
| dc.subject.other | phenol derivative | |
| dc.subject.other | plant extract | |
| dc.subject.other | plant medicinal product | |
| dc.subject.other | protocatechuic acid | |
| dc.subject.other | rutin hydrate | |
| dc.subject.other | trolox C | |
| dc.subject.other | unclassified drug | |
| dc.subject.other | antioxidant activity | |
| dc.subject.other | antiproliferative activity | |
| dc.subject.other | apoptosis | |
| dc.subject.other | Article | |
| dc.subject.other | cell cycle G1 phase | |
| dc.subject.other | chemical analysis | |
| dc.subject.other | chemical composition | |
| dc.subject.other | controlled study | |
| dc.subject.other | drug cytotoxicity | |
| dc.subject.other | drug efficacy | |
| dc.subject.other | drug mechanism | |
| dc.subject.other | enzyme activity | |
| dc.subject.other | ethnopharmacology | |
| dc.subject.other | evaluation study | |
| dc.subject.other | ferric reducing antioxidant power assay | |
| dc.subject.other | fibroblast | |
| dc.subject.other | flow cytometry | |
| dc.subject.other | high performance liquid chromatography | |
| dc.subject.other | human | |
| dc.subject.other | human cell | |
| dc.subject.other | luminometric analysis | |
| dc.subject.other | male | |
| dc.subject.other | mitochondrial membrane potential | |
| dc.subject.other | Morus nigra | |
| dc.subject.other | MTT assay | |
| dc.subject.other | normal human | |
| dc.subject.other | phytochemistry | |
| dc.subject.other | prostate cancer cell line | |
| dc.subject.other | spectrophotometry | |
| dc.title | Antiproliferative and apoptotic effect of Morus nigra extract on human prostate cancer cells | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| rdl.citation.openalex | 78 | |
| rdl.citation.scopus | 71 | |
| rdl.citation.wos | 66 | |
| rdl.department | Department of Genetic and Bioengineering, Faculty of Engineering and Natural Sciences, Gumushane University, 29100 Gumushane, Turkey | |
| rdl.department | Medicinal Plants, Traditional Medicine Practice and Research Center, Gumushane University, 29100 Gumushane, Turkey | |
| rdl.department | Department of Nutrition and Dietetics, School of Health Services, Gumushane University, 29100 Gumushane, Turkey | |
| rdl.oa.status | hybrid | |
| rdl.oa.url | https://www.sciencedirect.com/science/article/pii/S1319016416300603/pdf | |
| rdl.sdg | SDG03 | |
| rdl.source.index | SCOPUS | |
| rdl.source.index | WOS | |
| rdl.source.index | PUBMED | |
| rdl.wos.index | Science Citation Index Expanded (SCI-EXPANDED) |

